Catania Chiara, Spitaleri Gianluca, Del Signore Ester, Attili Ilaria, Radice Davide, Stati Valeria, Gianoncelli Letizia, Morganti Stefania, de Marinis Filippo
Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Front Oncol. 2020 Oct 14;10:584612. doi: 10.3389/fonc.2020.584612. eCollection 2020.
In February 2020, Italy became one of the first countries to be plagued by the SARS-CoV-2 pandemic, COVID-19. In March 2020, the Italian government decreed a lockdown for the whole country, which overturned communication systems, hospital organization, and access to patients and their relatives and carers. This issue had a particular regard for cancer patients. Our Thoracic Oncology Division therefore reorganized patient access in order to reduce the risk of contagion and, at the same time, encourage the continuation of treatment. Our staff contacted all patients to inform them of any changes in treatment planning, check that they were taking safety measures, and ascertain their feelings and whether they had any COVID-19 symptoms. To better understand patients' fears and expectations of during the pandemic period, we created a nine-question interview, administered from April to May 2020 to 156 patients with lung cancer. Patients were classified by age, sex, comorbidity, disease stage, prior treatment, and treatment type. The survey showed that during the pandemic period some patients experienced fear of COVID-19, in particular: women (55% vs. 33%), patients with comorbidities (24% vs. 9%), and patients who had already received prior insult (radiotherapy or surgery) on the lung (30% vs. 11%). In addition, the patients who received oral treatment at home or for whom intravenous treatment was delayed, experienced a sense of relief (90% and 72% respectively). However, only 21% of the patients were more afraid of COVID-19 than of their cancer, in particular patients with long-term (> 12 months) vs. short-term cancer diagnosis (28% vs. 12.5%, respectively). Furthermore, the quarantine period or even just the lockdown period alone, worsened the quality of life of some patients (40%), especially those in oral treatment (47%). Our data demonstrate how lung cancer patients are more afraid of their disease than of a world pandemic. Also this interview indirectly highlights the clinician's major guiding principle in correctly and appropriately managing not just the patient's expectations of their illness and its treatment, but also and especially of the patient's fears.
2020年2月,意大利成为首批受严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行——新型冠状病毒肺炎(COVID-19)困扰的国家之一。2020年3月,意大利政府颁布全国封锁令,这颠覆了通信系统、医院组织以及接触患者及其亲属和护理人员的方式。这个问题对癌症患者尤为重要。因此,我们的胸科肿瘤学部门重新安排了患者就诊流程,以降低传染风险,同时鼓励继续治疗。我们的工作人员联系了所有患者,告知他们治疗计划的任何变化,检查他们是否采取了安全措施,并了解他们的感受以及是否有任何COVID-19症状。为了更好地了解患者在大流行期间的恐惧和期望,我们设计了一份包含九个问题的访谈问卷,于2020年4月至5月对156名肺癌患者进行了调查。患者按年龄、性别、合并症、疾病阶段、既往治疗情况和治疗类型进行分类。调查显示,在大流行期间,一些患者对COVID-19感到恐惧,特别是:女性(55%对33%)、有合并症的患者(24%对9%)以及肺部已接受过先前损伤(放疗或手术)的患者(30%对11%)。此外,在家接受口服治疗或静脉治疗延迟的患者感到如释重负(分别为90%和72%)。然而,只有21%的患者更害怕COVID-19而非癌症,特别是长期(>12个月)与短期癌症诊断的患者(分别为28%对12.5%)。此外,隔离期甚至仅仅是封锁期本身,都使一些患者的生活质量下降(40%),尤其是接受口服治疗的患者(47%)。我们的数据表明肺癌患者更害怕自己的疾病而非全球大流行。这次访谈还间接凸显了临床医生的主要指导原则,即不仅要正确且适当地管理患者对疾病及其治疗的期望,更要尤其关注患者的恐惧。